SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Godavari Drugs informs about trading window closure

30 Dec 2023 Evaluate
Godavari Drugs has informed that the Trading Window for dealing in Shares of the Company for all the designated persons and their immediate relatives shall remain closed from 30.12.2023 till the completion of 48 hours after the declaration of un-audited financial results of the Company for the third quarter and nine months ended 31.12.2023. The date of board meeting for the consideration of un-audited financial results of the Company for the third quarter and nine months ended 31.12.2023 shall be intimated in due course of time.

The above information is a part of company’s filings submitted to BSE.

Godavari Drugs Share Price

125.15 7.44 (6.32%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×